share_log

Cardio Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director Burton Paul Frederick

Cardio Diagnostics | 4:持股變動聲明-董事 Burton Paul Frederick

美股sec公告 ·  02/22 07:08
牛牛AI助理已提取核心訊息
In a recent transaction dated 01/23/2024, Paul Frederick Burton engaged in a stock market activity involving shares of Cardio Diagnostics Holdings, Inc. (CDIO.US). The specifics of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the resulting total value of shares held by Burton after the action, have not been disclosed. The relationship of Burton to the issuer was not specified in the announcement.
In a recent transaction dated 01/23/2024, Paul Frederick Burton engaged in a stock market activity involving shares of Cardio Diagnostics Holdings, Inc. (CDIO.US). The specifics of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the resulting total value of shares held by Burton after the action, have not been disclosed. The relationship of Burton to the issuer was not specified in the announcement.
在最近於2024年1月23日進行的一筆交易中,保羅·弗雷德裏克·伯頓參與了一項涉及心臟診斷控股公司(CDIO.US)股票的股票市場活動。該交易的細節,包括交易的股票數量、股票的性質、交易價格以及伯頓在行動後持有的股票的總價值,尚未披露。公告中沒有具體說明伯頓與發行人的關係。
在最近於2024年1月23日進行的一筆交易中,保羅·弗雷德裏克·伯頓參與了一項涉及心臟診斷控股公司(CDIO.US)股票的股票市場活動。該交易的細節,包括交易的股票數量、股票的性質、交易價格以及伯頓在行動後持有的股票的總價值,尚未披露。公告中沒有具體說明伯頓與發行人的關係。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。